U.S. Hotel and Resort REITs Stock News

Capital One Financial has delivered a 92.4% share price gain over the past three years, yet its current checks still point to a stock that screens as undervalued rather than fully priced in. Both the Excess Returns intrinsic value estimate and market multiples lean in the same direction, which puts more focus on whether that apparent discount is justified by the risks now in view. Over the past three years the stock is up 92.4%. This means anyone looking at Capital One Financial today is...

General Electric (GE) is back in focus after Philippine Airlines agreed to use its GEnx 1B engines on a future Boeing 787 10 fleet, drawing attention to the company’s commercial aerospace franchise. See our latest analysis for General Electric. That Philippine Airlines deal arrives as General Electric shares hold at US$360.07, with a 90 day share price return of 25.67% and a 1 year total shareholder return of 34.34%. This points to momentum that has built over a multi year period, despite a...

In July 2026, National Bank Holdings Corporation reported second-quarter and first-half 2026 results, with net interest income rising to US$109.29 million for the quarter and US$218.09 million for the half-year, while net income and earnings per share from continuing operations declined compared with the prior year periods. Alongside these mixed earnings, the company also completed a tranche of its January 2026 share repurchase program, buying back 664,579 shares for US$27.21 million in...

Regeneron Pharmaceuticals stock jumped about 3% to around US$763 after its latest report, a clear sign traders liked what they saw in the headline numbers. The bigger story sits in the profit engine behind that move. Quarterly basic earnings per share came in at US$12.62 on revenue of US$4.29b, while trailing net margin stands at 27.9%, compared with 31.4% a year earlier. In the short term, the market is cheering the earnings print. Over a longer horizon, investors now have to weigh that...

In July 2026, Red Cat Holdings, Inc. disclosed that its Board had decided to terminate Chief Revenue Officer Geoffrey Hitchcock for cause, prompting Hitchcock to file a civil complaint alleging retaliatory termination, breach of contract, and related claims, while the company denies wrongdoing and plans a vigorous legal defense without severance or accelerated equity for him. On the upside for operations, Red Cat’s Teal Drones subsidiary secured a US$2.49 million firm-fixed-price contract...

STERIS plc has increased its quarterly interim dividend to US$0.69 per share, up US$0.06, marking its 21st consecutive year of dividend growth, with the payment made on 25 September 2026 to shareholders of record on 4 September 2026. This extended streak of rising dividends underlines management’s consistent commitment to shareholder returns and may matter for investors focused on income reliability. We’ll now examine how this higher quarterly dividend and long track record of dividend...

Cigna Group stock was essentially flat over the past month going into the earnings release, then slipped almost 3% to about US$279 as investors digested the latest numbers. The market is reacting to headlines, but the earnings story centers on profit power. Adjusted EPS guidance has been lifted to at least US$30.45 for 2026, while quarterly adjusted EPS came in at US$7.78 on US$71.7 billion of revenue. That combination of a sliding share price and firmer earnings guidance sets up a clear...

ACM Research (ACMR) has drawn investor attention after recent share price swings, including a decline of about 33% over the past month while still showing a very large total return over the past 3 years. See our latest analysis for ACM Research. Recent trading has been choppy for ACM Research, with the share price down about 33% over the past month and 7% over the past week. However, the year to date share price return of about 75% and a very large three year total shareholder return suggest...

Belden stock jumped about 6% today to roughly US$124 after investors reacted to a Q2 earnings beat that leaned heavily on profits rather than just top line growth. Adjusted earnings per share reached US$2.34 on US$750.2m of revenue, which put fresh attention on how much profit Belden can squeeze from each networking and industrial automation dollar. The short term move is eye catching. The bigger story is the long term profit engine that investors now have to weigh against a more leveraged...

Iovance Biotherapeutics stock has delivered a strong rebound over the past year, yet longer term holders are still facing steep losses, so the current valuation attracts close attention. The share price now sits against a backdrop where the broader checks lean cheap. This raises the question of whether the market is still underpricing the company or simply adjusting after a difficult few years. Over 5 years, Iovance Biotherapeutics is down 82.7%, which means many long term investors are...

Johnson & Johnson (NYSE:JNJ) has completed its acquisition of Firefly Bio, adding a degrader antibody therapy platform to its oncology toolkit. The company has entered an in vivo CAR-T alliance with Sail Biomedicines, focused on next generation cell therapy approaches. RYBREVANT FASPRO received FDA Priority Review for use in advanced head and neck cancer, with the application accepted in the past week. Johnson & Johnson is already a large player in pharmaceuticals and medical devices, and...

In July 2026, Gentherm Incorporated reported second-quarter 2026 net income of US$4.42 million and diluted EPS of US$0.14 from continuing operations, alongside the completion of a prior 1,021,070‑share buyback for US$39.9 million and the authorization of a new share repurchase program of up to US$400 million through July 2029. This combination of stronger profitability and a larger, freshly approved repurchase authorization signals management’s confidence in the business while potentially...

Shinhan Bank previously announced a partnership with StoneX Group Inc.’s Payments Division to integrate StoneX Payments’ platform, extending comprehensive cross-border payment and foreign exchange services across more than 140 currencies and 180 countries through a network of over 385 banks. This collaboration deepens StoneX’s presence in South Korea and the wider Asia-Pacific region by supporting high-volume, complex flows into thinly traded currency corridors in Latin America, the Middle...

NBT Bancorp Inc. recently reported second-quarter 2026 results, with net interest income of US$136.96 million and net income of US$53.03 million, alongside higher loan net charge-offs of US$4.24 million compared with the prior year. The company also approved a third-quarter 2026 dividend of US$0.40 per share, its fourteenth consecutive annual increase, and completed a US$44.11 million share repurchase program that reduced its share count by 2.39%, signaling ongoing emphasis on shareholder...

Tenable Holdings (TENB) is back in focus after its 29 July 2026 earnings release. The results beat internal guidance, were followed by higher full year targets, and highlighted rapid uptake of the Tenable One exposure management platform. See our latest analysis for Tenable Holdings. Tenable Holdings' recent earnings beat, higher guidance and ongoing share repurchases have come against a backdrop of mixed returns, with a 90 day share price return of 53.72% and a 3 year total shareholder...

Korn Ferry recently highlighted its role in helping companies turn staffing into a core strategic function, supported by digital innovation and AI, while also reporting its fifth consecutive quarter of top-line growth across multiple service lines. This combination of workforce-transformation positioning and consistent revenue momentum appears to be reinforcing investor confidence in Korn Ferry’s broader business model. Next, we’ll examine how Korn Ferry’s AI-enabled workforce transformation...

Upbound Group stock was already on the back foot coming into this print, with the share price down over the past month, and the market clipped it another 3.6% to about US$19.40 after the release. That move reflects nerves about pressure where it hurts most, in profitability and balance sheet flexibility. The headline from this quarter is a profit squeeze sitting on top of a leverage story. Adjusted EBITDA came in at US$127 million and non GAAP earnings per share at US$1.07, while net debt...

Ashland Inc. reported past third-quarter 2026 results showing sales of US$497 million and net income of US$16 million, a shift from a very large net loss a year earlier, while also reaffirming full-year sales guidance of US$1.84 billion to US$1.87 billion. Alongside the earnings update, Ashland added two independent directors and formed a Capital Allocation Advisory Committee in cooperation with a significant shareholder, signaling increased focus on how it deploys cash and shapes long-term...

Four Corners Property Trust recently reported second-quarter 2026 results showing year-over-year growth in revenue and net income, alongside a record US$382 million of acquisitions and new long-term credit facilities that expand its borrowing capacity to US$1.15 billion. By pairing high-occupancy portfolio growth, including acquisitions like Mission Pet Health and Sun Auto Tire & Service, with lower-cost, longer-dated debt, the REIT is reinforcing its focus on essential, net-leased...

Crocs stock came into this print with a mixed backdrop for investors. The share price was up strongly over the past 3 months, yet the 7 day move was slightly negative. The instant verdict after the Q2 release was clear. The stock climbed about 3.5% to around US$128. The headline was not just another solid quarter. Crocs posted about US$1.2b in revenue and adjusted earnings per share of US$4.55, and management lifted both full year sales and earnings guidance. For a company often treated as a...

BGC Group went into this earnings print with the stock roughly flat over the past month and down slightly in the last week, then slipped another 1.4% to about US$11.50 after the numbers hit. That reaction sits awkwardly against a quarter built around margin strength rather than headline revenue. The real story is profit quality. Adjusted pretax earnings reached US$192.9m and adjusted earnings before interest, tax, depreciation and amortisation came in at US$228.7m, both higher than a year...

Brunswick stock barely flinched after earnings, slipping less than 1% to about US$79, even as the boating group delivered one of its cleanest quarters in years. Revenue landed at about US$1.6b and adjusted earnings per share reached roughly US$1.56, with all major segments contributing. The short term price move tells you very little about the real story. For anyone thinking beyond this week, the focus now shifts to how this stronger profit run, rising free cash flow and updated guidance...

Guardant Health jumped 6.3% to about US$162, and that pop highlights today’s sentiment tug of war. The stock came in after a flat week and a rough month, yet traders quickly latched onto one thing. Q2 revenue reached about US$335 million, with Screening revenue climbing to US$53 million as Shield testing scaled up, while the company still reported a loss of roughly US$120 million. This is a classic sentiment reckoning. The market is focusing on the growth story and Shield momentum, while the...

Nomad Foods (NOMD) drew fresh attention after refinancing its capital structure through a €800 million senior secured notes offering due 2033 and increasing revolving credit facility commitments by €105 million, with proceeds applied to repay 2028 notes. See our latest analysis for Nomad Foods. Against this refinancing backdrop, Nomad Foods’ share price shows mixed momentum, with a 90 day share price return of 25% but a 1 year total shareholder return that declined 25.84%. This suggests...